Nvidia has largely dominated the artificial intelligence (AI) narrative over the last few years thanks to its combination of leading chips and software.

Get insights from Denali Therapeutics’ CEO on blood-brain barrier therapies, regulatory milestones, and biotech innovation.

Gonçalo Perdigão, entrepreneur and consultant with two decades of experience in strategy and innovation across sectors, examines how global regulation is reshaping the contest for A.I. leadership.

Santa Clara, California - September 08, 2025 - In 2025, the landscape for software engineers aiming to break into FAANG ...

The 2025 Bioprocessing Summit revealed knowledge gaps and changing mindsets. As some companies look towards the future, ...

Hospitals may soon have a faster option, thanks to a groundbreaking system built in part by Sneha Goenka, an assistant ...

Dauvilliers Y, Antczak J, Buntinx E, et al. Efficacy and safety of Oveporexton (TAK-861) for the treatment of narcolepsy type 1: results from a phase 3 randomized study in Asia, Australia, and Europe.

China's latest push to urge rational competition and regulate the promotional activities of major food delivery platforms ...

Investing in pre-IPO shares of Viz.ai could offer strong returns if the company’s valuation increases following its IPO. It’s ...

Cradle taps global expertise through strategic hiring and visa programs like the Highly Skilled Migrant Visa to build one of ...

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze ...

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms—addressing a ...